Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Grail (GRAL) Asset Writedowns and Impairment (2023 - 2025)

Historic Asset Writedowns and Impairment for Grail (GRAL) over the last 3 years, with Q2 2025 value amounting to $28.0 million.

  • Grail's Asset Writedowns and Impairment fell 9802.95% to $28.0 million in Q2 2025 from the same period last year, while for Sep 2025 it was $28.3 million, marking a year-over-year decrease of 9801.03%. This contributed to the annual value of $1.4 billion for FY2024, which is 9777.36% up from last year.
  • Latest data reveals that Grail reported Asset Writedowns and Impairment of $28.0 million as of Q2 2025, which was down 9802.95% from $273000.0 recorded in Q1 2025.
  • Grail's Asset Writedowns and Impairment's 5-year high stood at $1.4 billion during Q2 2024, with a 5-year trough of $273000.0 in Q1 2025.
  • For the 3-year period, Grail's Asset Writedowns and Impairment averaged around $541.9 million, with its median value being $373.2 million (2023).
  • Examining YoY changes over the last 5 years, Grail's Asset Writedowns and Impairment showed a top increase of 9802.95% in 2025 and a maximum decrease of 9802.95% in 2025.
  • Quarter analysis of 3 years shows Grail's Asset Writedowns and Impairment stood at $718.5 million in 2023, then skyrocketed by 97.77% to $1.4 billion in 2024, then plummeted by 98.03% to $28.0 million in 2025.
  • Its Asset Writedowns and Impairment was $28.0 million in Q2 2025, compared to $273000.0 in Q1 2025 and $1.4 billion in Q2 2024.